Human Influenza A(H1N1p) virus, A/LeMans/15006/2022 epidemic isolate, PA E199D mutation
virus

Human Influenza A(H1N1p) virus, A/LeMans/15006/2022 epidemic isolate, PA E199D mutation

ANTIVIRAL RESISTANT STRAIN

EVAg
Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
017V-05371
Human Influenza A(H1N1)pdm09 virus, A/LeMans/15006/2022, with PA E199D baloxavir resistance mutation, isolate of 2021-2022 epidemic season
Product Risk Group: 
RG2
ICTV Taxonomy: 
Riboviria / Orthornavirae / Negarnaviricota / Polyploviricotina / Insthoviricetes / Articulavirales / Orthomyxoviridae / Alphainfluenzavirus / Influenza A virus
Virus name: 
Influenza A virus (A/LeMans/15006/2022)
Strain: 
A/LeMans/15006/2022
Genotype: 
Genetic subgroup 6B.1A.5a.1
Serotype: 
A/Guangdong Maonan/SWL1536/2019

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
one vial

In stock

500,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

Special feature: 
Antiviral resistant strain
GMO: 
No
Biosafety restrictions: 
BSL2
Virus host type: 
Human virus
Infectivity Test: 
HA = 128, 1E8 PFU/ml
Production cell line: 
MDCK cells
Virus Cultivability: 
Cultivable virus
Passage: 
C2
Shipping conditions: 
Dry ice
IATA Classification: 
Category B, UN3373

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Thursday, 24 February, 2022
Country of collection: 
France
Suspected epidemiological origin : 
France
Isolation host: 
Human (female)
54 years old
Isolation technique: 
MDCK cells
Isolation conditions: 
35°C and 5% CO2, 1ug/ml TPCK-trypsin